Guidance for Monitoring and Evaluation of Community-Based Access to Injectable Contraception

The goal of this guidance is to strengthen CBA2I programs through improved M&E, resulting in increased access to and quality of family planning services. This guidance is intended for use by governments and programs or projects wanting to implement or improve their CBA2I programs, and specifically, the monitoring and evaluation of these programs.

File:

Guidance for Monitoring and Evaluation of Community-Based Access to Injectable Contraception (English) (891.12k)

Year:

2018

Organization:

FHI 360

Pfizer Foundation

Languages:

English

This website is made possible by the support of the American People through the United States Agency for International Development (USAID) under the Knowledge SUCCESS (Strengthening Use, Capacity, Collaboration, Exchange, Synthesis, and Sharing) Project. Knowledge SUCCESS is supported by USAID’s Bureau for Global Health, Office of Population and Reproductive Health and led by the Johns Hopkins Center for Communication Programs (CCP) in partnership with Amref Health Africa, The Busara Center for Behavioral Economics (Busara), and FHI 360. The contents of this website are the sole responsibility of CCP. The information provided on this website does not necessarily reflect the views of USAID, the United States Government, or the Johns Hopkins University. Read our full Security, Privacy, and Copyright Policies.